70 results
8-K
EX-1.1
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
a commitment by the Placement Agent to purchase the Placement Agent Securities and does not ensure the successful placement of the Placement Agent
8-K
EX-99.1
MTNB
Matinas Biopharma Holdings Inc
8 Nov 23
Matinas BioPharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
4:06pm
not change the projected study size (<200 patients) or enrollment timeline (22-24 mos.). The FDA has communicated its commitment to work
8-K
EX-99.1
jgs77l3 2dpj4bwl6
21 Oct 22
Matinas BioPharma Announces Positive Interim Data from the Phase 2
7:00am
8-K
EX-99.1
a9gdi
25 Jan 22
Matinas BioPharma Provides Business Update and 2022 Strategic Outlook
6:30am
8-K
EX-99.1
vwjtm pspwf4ej8dk5jr
13 Sep 21
Regulation FD Disclosure
6:05am